You have 9 free searches left this month | for more free features.

20-270

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Terminated
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +79 more
Oct 3, 2022

COVID-19, Sars-CoV-2 Infection Trial in Ankara, Istanbul (CoronaVac, Turkovac)

Active, not recruiting
  • COVID-19
  • Sars-CoV-2 Infection
  • CoronaVac
  • Turkovac
  • Ankara, Turkey
  • +3 more
Apr 4, 2022

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +4 more
  • West Hollywood, California
  • +101 more
Jan 16, 2023

Vasomotor Symptoms, Menopausal Symptoms Trial in Worldwide (Estetrol oral tablet, Placebo oral tablet, Progesterone oral tablet)

Recruiting
  • Vasomotor Symptoms
  • Menopausal Symptoms
  • Estetrol oral tablet
  • +2 more
  • Phoenix, Arizona
  • +188 more
May 9, 2022

Respiratory Depression, Cannabis Use, Opioid Use Trial in Leiden (Medicinal cannabis in combination with oxycodon, Medicinal

Recruiting
  • Respiratory Depression
  • +2 more
  • Medicinal cannabis in combination with oxycodon
  • Medicinal cannabis in combination with placebo oxycodon
  • Leiden, Zuid Holland, Netherlands
    Leiden University Medical Center
Feb 10, 2022

Severe Hemophilia A Subjects Who Received BMN 270 inPrior

Enrolling by invitation
  • Hemophilia A
    • London, United Kingdom
      Royal London Hospital, Barts and the London Hemophilia Center
    Mar 13, 2023

    Locally Advanced Cervical Cancer Trial in Worldwide (biological, drug, radiation)

    Active, not recruiting
    • Locally Advanced Cervical Cancer
    • Durvalumab
    • +3 more
    • Phoenix, Arizona
    • +117 more
    Oct 13, 2022

    Hemophilia A Trial in Worldwide (valoctocogene roxaparvovec)

    Active, not recruiting
    • Hemophilia A
    • valoctocogene roxaparvovec
    • Los Angeles, California
    • +47 more
    Dec 21, 2022

    Panoramic Radiography Trial in Tabriz (Fruit leather on the tongue, Chewing gum strip, Celluloid matrix group)

    Completed
    • Panoramic Radiography
    • Fruit leather on the tongue
    • +2 more
    • Tabriz, Iran, Islamic Republic of
      Department of Oral and Maxillofacial Surgery, Faculty of Dentist
    Nov 28, 2023

    Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density

    Active, not recruiting
    • Atherosclerotic Cardiovascular Disease
    • +2 more
    • Sale, Cheshire, United Kingdom
    • +16 more
    Jan 20, 2023

    Small Intestinal Bacterial Overgrowth, Gastrointestinal Disorder, Functional Trial (Olive leaf tea)

    Not yet recruiting
    • Small Intestinal Bacterial Overgrowth
    • Gastrointestinal Disorder, Functional
    • Olive leaf tea
    • (no location specified)
    Jun 13, 2023

    Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)

    Recruiting
    • Gastric Cancer
    • Gastroesophageal Junction Adenocarcinoma
    • Phoenix, Arizona
    • +119 more
    Feb 1, 2023

    Premenstrual Syndrome Trial in Malatya (Acupresur, Mindfulness, Plasebo)

    Active, not recruiting
    • Premenstrual Syndrome
    • Acupresur
    • +2 more
    • Malatya, Centre, Turkey
      Simge OZTURK
    Feb 1, 2023

    Schizophrenia Trial in Worldwide (BI 425809, Placebo)

    Recruiting
    • Schizophrenia
    • Garden Grove, California
    • +102 more
    Jan 27, 2023

    Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

    Not yet recruiting
    • Pancreatic Cancer Metastatic
    • C3 (Metformin, Simvastatin, and Digoxin)
    • (no location specified)
    Sep 1, 2023

    Niemann-Pick Disease, Type C Trial in Worldwide (Parts A/B: Adrabetadex, Parts A/B: Sham Control)

    Active, not recruiting
    • Niemann-Pick Disease, Type C
    • Parts A/B: Adrabetadex
    • Parts A/B: Sham Control
    • Birmingham, Alabama
    • +28 more
    Jul 23, 2021

    Migraine Disorders, Headache Disorders Trial in Hangzhou (Placebo, 90mg Idebenone, 270mg Idebenone)

    Recruiting
    • Migraine Disorders
    • Headache Disorders
    • Placebo
    • +2 more
    • Hangzhou, Zhejiang, China
      Kaiming Liu
    Jun 12, 2021

    Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)

    Active, not recruiting
    • Renal Cell Carcinoma
    • La Jolla, California
    • +159 more
    Jan 23, 2023

    Urothelial Cancer Trial in Worldwide (Avelumab, Best Supportive Care, Following the planned interim analysis for this study:

    Active, not recruiting
    • Urothelial Cancer
    • Avelumab
    • +2 more
    • Aurora, Colorado
    • +370 more
    Oct 24, 2022

    GERD, Bariatric Surgery, Laparoscopic Sleeve Gastrectomy Trial (Cardia Band Ligation)

    Withdrawn
    • GERD
    • +2 more
    • Cardia Band Ligation
    • (no location specified)
    Sep 22, 2021

    Healthy Trial in Lund (Polar lipid 1, Polar lipid 2, Non-polar lipids)

    Recruiting
    • Healthy
    • Polar lipid 1
    • +3 more
    • Lund, Välj..., Sweden
      Lund University, dep of Food Technology, Engineering, and Nutrit
    Nov 28, 2023

    Population With Hypertension in Primary Care

    Recruiting
    • Hypertension
    • +2 more
    • Alcohol biomarker Phosphatidylethanol (PEth)
    • Stockholm, Sweden
      Region Stockholm
    Oct 18, 2022

    Gastroesophageal Reflux Disease Trial in Mexico City (Ablation of the gastroesophageal junction with hybrid argon plasma,

    Recruiting
    • Gastroesophageal Reflux Disease
    • Ablation of the gastroesophageal junction with hybrid argon plasma
    • mucosectomy with band of the gastroesophageal junction
    • Mexico City, Mexico
      Centro Medico Nacional Siglo XXI Hospital de Especialidades
    Jul 21, 2022

    Crohn's Disease Trial in Worldwide (V565, Placebo)

    Completed
    • Crohn's Disease
    • Anaheim, California
    • +93 more
    Nov 24, 2021

    Systemic Lupus Erythematosus Trial in Worldwide (BOS161721, Placebo)

    Completed
    • Systemic Lupus Erythematosus
    • Anniston, Alabama
    • +67 more
    Feb 16, 2022